Artesunate Vaginal Inserts for Cervical Dysplasia
Artesunate Vaginal Inserts for the Treatment of Cervical Intraepithelial Neoplasia (CIN2/3)
- Age
- 25 – 100
- Sex
- Female
- Trial phase
- Phase 2
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 78 (estimated)
- Sponsor
- Frantz Viral Therapeutics, LLC · Industry
This trial is looking for women aged 25 and older who have been diagnosed with high grade cervical lesions. Participants will use Artesunate vaginal inserts and be monitored throughout the study.
You may be able to join if
- I am a woman aged 25 or older.
- I can give informed consent.
- I have any HPV type detected by a test.
- I have been diagnosed with cervical high grade lesions.
- I agree to use birth control if I can become pregnant.
- I weigh 50 kg or more.
You may not be able to join if
- I am currently pregnant or nursing.
- I have an active autoimmune disease.
- I am taking immunosuppressive medication.
- I am HIV positive.
- I am immunocompromised.
- I have cervical adenocarcinoma in situ.
- I have another cancer apart from nonmelanoma skin lesions.
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.
Check Your EligibilityThis is a phase II double blind, placebo-controlled, randomized study of Artesunate vaginal inserts for the treatment of women who have cervical high grade intraepithelial neoplasia (CIN2/3).
Loading trial locations…